Allina Health System
Allina Health System was paid $5.49M by Medicaid between Jan 2018 and Dec 2024, across 132 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
WOODBURY, MN 55125
Next to other Clinic/Center providers in Minnesota
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26,916 | $257K | |
| 2019 | 25,199 | $963K | |
| 2020 | 25,028 | $1.02M | |
| 2021 | 30,605 | $1.34M | |
| 2022 | 16,678 | $768K | |
| 2023 | 14,173 | $631K | |
| 2024incomplete | 10,619 | $508K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 28,312 | 25,320 | $1.96M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 17,956 | 16,383 | $822K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 13% | 5,832 | 5,456 | $725K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 3.1% | 2,128 | 2,088 | $170K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.3% | 4,110 | 4,036 | $126K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 2.2% | 1,870 | 1,233 | $123K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.1% | 1,393 | 1,349 | $113K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.6% | 1,294 | 1,255 | $88K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.6% | 1,208 | 1,196 | $85K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.5% | 986 | 841 | $81K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.5% | 874 | 845 | $80K |
| X5622 | 1.3% | 1,956 | 1,884 | $73K |
120 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.1% | 598 | $62K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.0% | 881 | $55K |
| 92015 | Determination of refractive state | <1% | 4,023 | $47K |
| 36415 | Collection of venous blood by venipuncture | <1% | 16,000 | $45K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 1,802 | $43K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 6,409 | $39K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 543 | $37K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,785 | $33K |
| 99417 | Prolong home eval add 15m | <1% | 461 | $29K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 847 | $26K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,105 | $26K |
| 80061 | Lipid panel | <1% | 2,062 | $25K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,610 | $24K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 724 | $23K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 211 | $23K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 617 | $22K |
| 97810 | <1% | 886 | $22K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 803 | $20K |
| 90686 | <1% | 3,290 | $20K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,287 | $20K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 235 | $20K |
| 80053 | Comprehensive metabolic panel | <1% | 1,974 | $19K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 581 | $19K |
| 97811 | <1% | 885 | $17K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 755 | $16K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,865 | $16K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,641 | $16K |
| 92551 | <1% | 2,690 | $15K | |
| V2020 | Frames, purchases | <1% | 611 | $13K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 338 | $12K |
| 99188 | <1% | 1,536 | $12K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 183 | $11K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 84 | $11K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 117 | $10K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 631 | $9K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 122 | $8K |
| 92567 | <1% | 730 | $8K | |
| 97803 | <1% | 180 | $8K | |
| 81514 | <1% | 31 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 917 | $7K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 129 | $7K |
| 0064A | <1% | 182 | $6K | |
| 0002A | <1% | 227 | $6K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 248 | $6K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 470 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 772 | $5K |
| 0001A | <1% | 247 | $5K | |
| 82728 | <1% | 408 | $5K | |
| 86003 | <1% | 74 | $5K | |
| 92341 | <1% | 164 | $5K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 287 | $5K |
| 87481 | <1% | 134 | $5K | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 187 | $4K |
| 92557 | <1% | 175 | $4K | |
| 81001 | <1% | 1,600 | $4K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 110 | $4K |
| 80050 | General health panel | <1% | 68 | $3K |
| 99243 | <1% | 39 | $3K | |
| 82607 | <1% | 188 | $3K | |
| 87081 | <1% | 975 | $3K | |
| 85027 | <1% | 428 | $3K | |
| 85018 | <1% | 1,333 | $3K | |
| 86780 | <1% | 201 | $2K | |
| 90715 | <1% | 184 | $2K | |
| 90651 | <1% | 98 | $2K | |
| 99173 | <1% | 2,314 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 50 | $2K |
| 99205 | Prolong outpt/office vis | <1% | 12 | $2K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 61 | $2K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 154 | $2K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 80 | $2K |
| 90837 | Psychotherapy session, about an hour | <1% | 29 | $2K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 227 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 161 | $1K |
| 90670 | <1% | 528 | $1K | |
| G0008 | Administration of influenza virus vaccine | <1% | 162 | $1K |
| 31575 | <1% | 14 | $983.03 | |
| 96127 | <1% | 271 | $861.66 | |
| 86803 | <1% | 58 | $829.89 | |
| 99242 | <1% | 14 | $787.02 | |
| 87660 | <1% | 40 | $778.63 | |
| 87510 | <1% | 40 | $778.63 | |
| 87480 | <1% | 40 | $778.63 | |
| 0012A | <1% | 33 | $762.26 | |
| 81025 | <1% | 189 | $729.81 | |
| 90656 | <1% | 109 | $664.46 | |
| 36416 | <1% | 245 | $618.82 | |
| 90653 | <1% | 30 | $616.00 | |
| 99177 | <1% | 172 | $612.29 | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 13 | $575.03 |
| 93000 | <1% | 58 | $568.10 | |
| 94010 | <1% | 30 | $526.07 | |
| 87150 | <1% | 12 | $449.34 | |
| 0011A | <1% | 37 | $433.38 | |
| 90480 | <1% | 14 | $342.88 | |
| 82947 | <1% | 56 | $220.44 | |
| 92587 | <1% | 14 | $179.40 | |
| 83540 | <1% | 26 | $176.58 | |
| 87210 | <1% | 58 | $162.76 | |
| 99000 | <1% | 76 | $150.00 | |
| 90716 | <1% | 70 | $144.72 | |
| 86140 | <1% | 26 | $132.78 | |
| 83550 | <1% | 13 | $121.12 | |
| 90691 | <1% | 12 | $116.93 | |
| 82043 | <1% | 12 | $74.60 | |
| 99459 | <1% | 25 | $56.68 | |
| 99442 | <1% | 16 | $47.74 | |
| 85652 | <1% | 15 | $37.15 | |
| 81003 | <1% | 87 | $29.57 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 1,030 | $0.50 |
| 90734 | 0% | 45 | $0.00 | |
| 90633 | 0% | 38 | $0.00 | |
| 90707 | 0% | 55 | $0.00 | |
| 91300 | 0% | 32 | $0.00 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 0% | 13 | $0.00 |
| 84439 | 0% | 16 | $0.00 | |
| 90723 | 0% | 198 | $0.00 | |
| 90647 | 0% | 127 | $0.00 | |
| 90677 | 0% | 51 | $0.00 | |
| 76830 | Ultrasound, transvaginal | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Allina Health System | Saint Paul, MN | $118.02M |
| Allina Health System | Coon Rapids, MN | $22.13M |
| Allina Health System | Minneapolis, MN | $18.26M |
| Allina Health System | Cambridge, MN | $13.17M |
| Allina Health System | St Paul, MN | $10.77M |
| Allina Health System | Faribault, MN | $7.56M |
| Allina Health System | New Ulm, MN | $7.47M |
| Allina Health System | Fridley, MN | $7.34M |
| Allina Health System | Minneapolis, MN | $5.35M |
| Allina Health System | Bloomington, MN | $4.38M |
| Allina Health System | Northfield, MN | $4.36M |
| Allina Health System | Hastings, MN | $4.22M |
| Allina Health System | Maplewood, MN | $4.15M |
| Allina Health System | West St Paul, MN | $3.64M |
| Allina Health System | Cottage Grove, MN | $3.63M |
| Allina Health System | Minneapolis, MN | $3.54M |
| Allina Health System | Eagan, MN | $3.39M |
| Allina Health System | St Paul, MN | $3.35M |
| Allina Health System | Shakopee, MN | $2.81M |
| Allina Health System | Eden Prairie, MN | $2.71M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.